Skip to content
The Policy VaultThe Policy Vault

ZyvoxCareFirst (Caremark)

Pulmonary tuberculosis resistant to isoniazid and rifampin that is treatment-intolerant or nonresponsive to standard therapy

Initial criteria

  • The requested drug is being prescribed as part of a combination regimen with Pretomanid AND Sirturo (bedaquiline).
  • The patient will use the requested drug orally or intravenously.

Approval duration

12 months